CVS, a veterinary services group, says its portrayal of the industry has been “disappointing” as reforms take effect. The company’s comments come alongside its announcement of its first acquisition in the UK.
The reports tie the acquisition timing to the end of a Competition and Markets Authority (CMA) probe, noting that CVS makes the deal shortly after the CMA’s conclusion. Both outlets frame the acquisition as a near-term next step following regulatory review, but the available coverage focuses most on CVS’s reaction to how the sector is described rather than on the substance of any specific reform measures.
Across the two sources, the core points remain the same: CVS criticizes the depiction of the industry, and it simultaneously announces its first UK acquisition. The outlets do not add further detail on the acquisition terms or on what aspects of the reforms or portrayal CVS finds most inaccurate.
